Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

NETWORK 1

Study Type

Observational 1

Sponsor

Cancer Type

CNS 1

Conditions

Brain Neoplasms 4Neuroblastoma 3Glioma 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pinealoma 1Neoplasms, Germ Cell and Embryonal 1Meningioma 1Hemangiopericytoma 1Hemangioma, Cavernous, Central Nervous System 1Hemangioma, Cavernous 1Hemangioblastoma 1Gliosarcoma 1Glioblastoma 1Ganglioneuroblastoma 1Ependymoma 1Choroid Plexus Neoplasms 1Cardiotoxicity 1Breast Neoplasms 1

Interventions

pembrolizumab 1Watchful Waiting 1Proton Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hemangiopericytoma × Watchful Waiting × CNS × Clear all
NCT05259605 2025-12-17

Observational Study for Assessing Treatment and Outcome of Patients With Primary Brain Tumours Using cIMPACT-NOW and 2021 WHO Classification

European Organisation for Research and Treatment of Cancer - EORTC

Recruiting
1,650 enrolled
CNS

Ependymoma, Glioma, Hemangiopericytoma, Neoplasms, Germ Cell and Embryonal, Pinealoma, Choroid Plexus Neoplasms, Hemangioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡